A, C., EK, T., R, N., P, A., C, B., K, D., . . . HJ, S. (2022). American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: January 2022 update on the use of therapeutic-intensity anticoagulation in acutely ill patients. Blood advances, 6(17), 4915. https://doi.org/10.1182/bloodadvances.2022007561
Chicago Style (17th ed.) CitationA, Cuker, et al. "American Society of Hematology Living Guidelines on the Use of Anticoagulation for Thromboprophylaxis in Patients with COVID-19: January 2022 Update on the Use of Therapeutic-intensity Anticoagulation in Acutely Ill Patients." Blood Advances 6, no. 17 (2022): 4915. https://doi.org/10.1182/bloodadvances.2022007561.
MLA (9th ed.) CitationA, Cuker, et al. "American Society of Hematology Living Guidelines on the Use of Anticoagulation for Thromboprophylaxis in Patients with COVID-19: January 2022 Update on the Use of Therapeutic-intensity Anticoagulation in Acutely Ill Patients." Blood Advances, vol. 6, no. 17, 2022, p. 4915, https://doi.org/10.1182/bloodadvances.2022007561.
